Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2021

Magro C, Nuovo G, J Mulvey J, Laurence J, Harp J, A Crowson N. The skin as a critical window in unveiling the pathophysiologic principles of COVID-19. Clin Dermatol. 2021;39(6):934-965.

Zhang BM, Keegan A, Li P, Lindeman NI, Nagarajan R, Routbort MJ, et al. An Overview of Characteristics of Clinical Next-Generation Sequencing-Based Testing for Hematologic Malignancies. Arch Pathol Lab Med. 2021;145(9):1110-1116.

Cacciatore S, Wium M, Licari C, Ajayi-Smith A, Masieri L, Anderson C, et al. Inflammatory metabolic profile of South African patients with prostate cancer. Cancer Metab. 2021;9(1):29.

Stupnikov A, Sizykh A, Budkina A, Favorov A, Afsari B, Wheelan S, et al. Hobotnica: exploring molecular signature quality. F1000Res. 2021;10:1260.

Hissong E, Yantiss RK. The Frontiers of Appendiceal Controversies: Mucinous Neoplasms and Pseudomyxoma Peritonei. Am J Surg Pathol. 2021;Publish Ahead of Print.

Jacob RP, Walsh EM, Maslak PG, Giralt SA, Avecilla ST. A simplified CD34+ based preharvest prediction tool for HPC(A) collection. Transfusion. 2021;61(5):1525-1532.

Weiner AB, Vidotto T, Liu Y, Mendes AA, Salles DC, Faisal FA, et al. Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes. Nat Commun. 2021;12(1):935.

Levitan D, London V, McLaren RA, Mann JD, Cheng K, Silver M, et al. Histologic and Immunohistochemical Evaluation of 65 Placentas From Women With Polymerase Chain Reaction-Proven Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Arch Pathol Lab Med. 2021;145(6):648-656.

Haque M, Singh AK, Ouseph MM, Ahmed S. Regulation of Synovial Inflammation and Tissue Destruction by Guanylate Binding Protein 5 in Synovial Fibroblasts From Patients With Rheumatoid Arthritis and Rats With Adjuvant-Induced Arthritis. Arthritis Rheumatol. 2021;73(6):943-954.

Bastos DC, Ribeiro CF, Ahearn T, Nascimento J, Pakula H, Clohessy J, et al. Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss. J Pathol. 2021;253(3):292-303.